prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2019
-
Epigenetic drug screen on CD20 immunotherapy resistant cells revealed possible role of Aurora kinase inhibitors in CD20 expression regulation.
Year: 2019, type: Conference abstract
-
Familial leukemia associated with thrombocytopenia
Germ Line Mutations Associated Leukemia, year: 2019, number of pages: 16 s.
-
Characterization of causal variants associated with hereditary thrombocytopenias.
Year: 2019, type: Conference abstract
-
Charakterizace genových aberací u dospělých pacientů s Ph-negativní akutní lymfoblastickou leukemií
Year: 2019, type: Conference abstract
-
Charakterizace patogenních variant u rodin s výskytem dědičné trombocytopenie – kazuistiky.
Year: 2019, type: Conference abstract
-
Chronická lymfocytární leukemie – současné využití moderních prognostických a prediktivních faktorů v diagnostice
Transfúze a hematologie dnes, year: 2019, volume: 25, edition: 1
-
Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience
Leukemia Research, year: 2019, volume: 81, edition: JUN 2019, DOI
-
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
The Lancet. Haematology, year: 2019, volume: 6, edition: 12, DOI
-
Léčba relabující/refrakterní akutní lymfoblastické leukemie dnes a zítra
Klinická onkologie, year: 2019, volume: 32, edition: 2
-
MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells
Leukemia, year: 2019, volume: 33, edition: 2, DOI